B
BUDA
Buda Juice, Inc.
10.25
-0.41-3.85%Pre Market: 10.43 +0.18 +1.76%04:10 04/09 EDT
OPEN/PREV CLOSE10.44/10.66
TODAY RANGE10.25-10.70
VOL1
MARKET CAP128.81M
52 WEEK RANGE6.85-12.00
AVG VOL (3M)44.49K
% TURNOVER0.04%
TURNOVER--
P/E (TTM)70.35
% RANGE1.69%
EPS(TTM)0.1457
P/E(FORWARD)--
P/B33.88
BVPS0.3025
DIVIDEND--
P/S11.52
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP39.83M
SHARES OUTSTANDING12.57M
NEXT EARNINGS--
FREE FLOAT3.89M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·03/28 09:35
Buda Juice: The Optionality Isn't Mine
Seeking Alpha·03/26 11:27
Buda Juice, Inc. GAAP EPS of $0.20, revenue of $12.61M
Benzinga·03/26 11:11
Earnings Scheduled For March 26, 2026
TipRanks·03/26 11:05
Buda Juice reports FY25 EPS 20c vs 20c last year
Benzinga·03/26 11:02
Buda Juice FY EPS $0.20, Same YoY, Sales $12.609M Up From $11.274M YoY
Dow Jones·03/26 11:00
*Buda Juice 2025 Rev $12.6M >BUDA
Dow Jones·03/26 11:00
Press Release: Buda Juice Reports Full Year -2-
Dow Jones·03/26 11:00
Press Release: Buda Juice Reports Full Year Fiscal 2025 Financial Results
Seeking Alpha·01/23 17:35
Buda Juice: A Cold Chain Story With Hot IPO Expectations
TipRanks·01/22 12:05
Buda Juice announces full exercise of underwriters’ over-allotment option
TipRanks·01/22 11:33
Buda Juice IPO Overallotment Exercise Boosts Growth Capital
TipRanks·01/12 16:15
Opening Day: Aktis Oncology raises $318M in 2026’s first biotech IPO
Seeking Alpha·01/10 03:05
U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO
TipRanks·01/09 21:32
Buda Juice Prices IPO and Lists on NYSE American
Seeking Alpha·01/08 19:15
Buda Juice trades higher in opening IPO action
Same Industry
Name/Symbol
Change%
Price